Cargando…
Analysis of clinical prognosis in patients with non-hepatic hyperammonemia
The aim of this study was to evaluate the association of non-hepatic hyperammonemia (NHH) with the prognosis of critically ill patients with NHH. According to the serum ammonia level, the patients with NHH (n = 498) were retrieved by us. The risk factors of the mortality with NHH patients were inves...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837986/ https://www.ncbi.nlm.nih.gov/pubmed/33546031 http://dx.doi.org/10.1097/MD.0000000000024157 |
_version_ | 1783643070138417152 |
---|---|
author | Li, Yun Zhou, Qi Song, Jian-Nan Chen, Xue-Zhao Zhang, Xi-Zhe Sun, Yi |
author_facet | Li, Yun Zhou, Qi Song, Jian-Nan Chen, Xue-Zhao Zhang, Xi-Zhe Sun, Yi |
author_sort | Li, Yun |
collection | PubMed |
description | The aim of this study was to evaluate the association of non-hepatic hyperammonemia (NHH) with the prognosis of critically ill patients with NHH. According to the serum ammonia level, the patients with NHH (n = 498) were retrieved by us. The risk factors of the mortality with NHH patients were investigated by conducting univariate and multivariate logistic regression analyses. A nomogram to predict the risk of hospital mortality was constructed. Receiver operating characteristic curve (ROC) analysis was conducted to compare nomogram (ammonia into a prognostic model, P1) with the simplified acute physiology II (SAPSII) and quick sequential organ failure assessment (qSOFA). Five independent factors for the mortality in patients with NHH were identified, including age, platelets, bun, hemoglobin, and ammonia. Models P1 using ammonia showed good prediction power. The AUROC of P1 (AUROC, 0.755 [95% CI, 0.713–0.796]) was higher than that of qSOFA (AUROC, 0.500 [95% CI, 0.449–0.551]), and SAPS II (AUROC, 0.703[95% CI, 0.658–0.748]). Ammonia was an independent prognostic predictor of mortality for NHH patients. We developed a nomogram that can predict hospital mortality with patients. Nomogram had superior discriminative power to qSOFA and SAPS II, indicating that the nomogram may have clinical utility. |
format | Online Article Text |
id | pubmed-7837986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-78379862021-01-28 Analysis of clinical prognosis in patients with non-hepatic hyperammonemia Li, Yun Zhou, Qi Song, Jian-Nan Chen, Xue-Zhao Zhang, Xi-Zhe Sun, Yi Medicine (Baltimore) 3900 The aim of this study was to evaluate the association of non-hepatic hyperammonemia (NHH) with the prognosis of critically ill patients with NHH. According to the serum ammonia level, the patients with NHH (n = 498) were retrieved by us. The risk factors of the mortality with NHH patients were investigated by conducting univariate and multivariate logistic regression analyses. A nomogram to predict the risk of hospital mortality was constructed. Receiver operating characteristic curve (ROC) analysis was conducted to compare nomogram (ammonia into a prognostic model, P1) with the simplified acute physiology II (SAPSII) and quick sequential organ failure assessment (qSOFA). Five independent factors for the mortality in patients with NHH were identified, including age, platelets, bun, hemoglobin, and ammonia. Models P1 using ammonia showed good prediction power. The AUROC of P1 (AUROC, 0.755 [95% CI, 0.713–0.796]) was higher than that of qSOFA (AUROC, 0.500 [95% CI, 0.449–0.551]), and SAPS II (AUROC, 0.703[95% CI, 0.658–0.748]). Ammonia was an independent prognostic predictor of mortality for NHH patients. We developed a nomogram that can predict hospital mortality with patients. Nomogram had superior discriminative power to qSOFA and SAPS II, indicating that the nomogram may have clinical utility. Lippincott Williams & Wilkins 2021-01-22 /pmc/articles/PMC7837986/ /pubmed/33546031 http://dx.doi.org/10.1097/MD.0000000000024157 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 3900 Li, Yun Zhou, Qi Song, Jian-Nan Chen, Xue-Zhao Zhang, Xi-Zhe Sun, Yi Analysis of clinical prognosis in patients with non-hepatic hyperammonemia |
title | Analysis of clinical prognosis in patients with non-hepatic hyperammonemia |
title_full | Analysis of clinical prognosis in patients with non-hepatic hyperammonemia |
title_fullStr | Analysis of clinical prognosis in patients with non-hepatic hyperammonemia |
title_full_unstemmed | Analysis of clinical prognosis in patients with non-hepatic hyperammonemia |
title_short | Analysis of clinical prognosis in patients with non-hepatic hyperammonemia |
title_sort | analysis of clinical prognosis in patients with non-hepatic hyperammonemia |
topic | 3900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837986/ https://www.ncbi.nlm.nih.gov/pubmed/33546031 http://dx.doi.org/10.1097/MD.0000000000024157 |
work_keys_str_mv | AT liyun analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia AT zhouqi analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia AT songjiannan analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia AT chenxuezhao analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia AT zhangxizhe analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia AT sunyi analysisofclinicalprognosisinpatientswithnonhepatichyperammonemia |